Literature DB >> 1526020

Immunochemical detection of group I and group II phospholipases A2 in human serum.

T J Nevalainen1, P T Kortesuo, E Rintala, F Märki.   

Abstract

Time-resolved fluoroimmunoassay was developed for the detection of synovial-type phospholipase A2 (s-PLA2) in human serum. This solid-phase, sandwich assay uses a polyclonal rabbit antibody raised against synovial-type group II PLA2 produced in Escherichia coli. No cross-reactions were detected between s-PLA2 and PLA2 from human or porcine pancreas, human ascitic fluid, or bee or cobra venom. In healthy individuals, the average concentration of s-PLA2 is 3.7 micrograms/L, with a 95% reference interval from 1.3 to 10.8 micrograms/L. We investigated pancreatic PLA2, which is a group I PLA2, and synovial-type group II PLA2 in sera of patients with hematological malignancies and septic fever. The concentration of s-PLA2 was increased in patient sera and correlated significantly with the catalytic activity of PLA2 and the concentration of C-reactive protein. No correlation with the concentration of pancreatic PLA2 was found. The results suggest that the increased catalytic activity of PLA2 in sera of patients with septic fever results from synovial-type group II PLA2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1526020

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  16 in total

1.  Pathophysiological role of secretory type I and II phospholipase A2 in acute pancreatitis: an experimental study in rats.

Authors:  W Uhl; H J Schrag; N Schmitter; T J Nevalainen; J Aufenanger; A M Wheatley; M W Büchler
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears.

Authors:  X D Qu; R I Lehrer
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  C/EBP factor suppression of inhibition of type II secreted phospholipase A2 promoter in HepG2 cells: possible role of single-strand binding proteins.

Authors:  Q Fan; M Paradon; C Salvat; G Bereziat; J L Olivier
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  Group IIA phospholipase A2 content of tears in patients with atopic blepharoconjunctivitis.

Authors:  Heikki Peuravuori; Osmo Kari; Sirje Peltonen; Valtteri V Aho; Jukka M Saari; Yrjö Collan; Marko Määttä; K Matti Saari
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-26       Impact factor: 3.117

5.  Phospholipase A2 isoforms are altered in chronic pancreatitis.

Authors:  M Kashiwagi; H Friess; W Uhl; H Graber; R Duarte; A Zimmermann; M W Büchler
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

6.  Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues.

Authors:  T J Nevalainen; T J Haapanen
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

7.  The expression and distribution of group IIA phospholipase A2 in human colorectal tumours.

Authors:  Tuulia Avoranta; Jari Sundström; Eija Korkeila; Kari Syrjänen; Seppo Pyrhönen; Jukka Laine
Journal:  Virchows Arch       Date:  2010-10-12       Impact factor: 4.064

8.  Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis.

Authors:  M Kashiwagi; H Friess; W Uhl; P Berberat; M Abou-Shady; M Martignoni; S E Anghelacopoulos; A Zimmermann; M W Büchler
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

9.  Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection.

Authors:  V J Laine; D S Grass; T J Nevalainen
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

10.  Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis.

Authors:  T J Nevalainen; J M Grönroos; P T Kortesuo
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.